Literature DB >> 25679971

Understanding bleeding in ebola virus disease.

Anita McElroy1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25679971      PMCID： PMC4667727     

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  17 in total

1.  Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival.

Authors:  R F Sadek; A S Khan; G Stevens; C J Peters; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

2.  Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

3.  Ebola haemorrhagic fever in Zaire, 1976.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors:  John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

5.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

6.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Authors:  K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

9.  Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.

Authors:  Adam MacNeil; Eileen C Farnon; Joseph Wamala; Sam Okware; Deborah L Cannon; Zachary Reed; Jonathan S Towner; Jordan W Tappero; Julius Lutwama; Robert Downing; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962
View more
  2 in total

1.  Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.

Authors:  Mark D Kieh; Elim M Cho; Ian A Myles
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

2.  Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Authors:  Punya Shrivastava-Ranjan; Mike Flint; Éric Bergeron; Anita K McElroy; Payel Chatterjee; César G Albariño; Stuart T Nichol; Christina F Spiropoulou
Journal:  MBio       Date:  2018-05-01       Impact factor: 7.867
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.